Drug Database
Back to search

United States· US:24208-434_37639b58-1d0f-206e-e063-6294a90a293a

Ofloxacin

A ofloxacin product containing ofloxacin, registered in United States by Bausch & Lomb Incorporated. The same ATC class is registered in 11 of our 19 countries.

ATC S01AE01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOfloxacinATCS01AE01REGISTER NO.US:24208-434_37639b58…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ofloxacinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ofloxacin is registered in 11 of 19 countries.

Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search ofloxacin products by name

Ofloxacin · ATC S01AE01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ofloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ofloxacin · price per daily dose (0.4 mg)

USD · FX 28 Sept 2026

  • FR France$0.0016
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OFLOXACIN
Manufacturer
Bausch & Lomb Incorporated
Country
United States (US)
ATC code
S01AE01
ATC class
Ofloxacin
Defined daily dose
0.4 mg, AT
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    2420843405
    1 BOTTLE, DROPPER in 1 CARTON (24208-434-05) / 5 mL in 1 BOTTLE, DROPPER
  • ndc11
    2420843410
    1 BOTTLE, DROPPER in 1 CARTON (24208-434-10) / 10 mL in 1 BOTTLE, DROPPER
  • ndc11
    24208-434-05
  • ndc11
    24208-434-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ofloxacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Floxal, Floxal Edo
  • Belgium · Trafloxal, Trafloxal Edo
  • Bulgaria · Медофлоксин, Офлоксацин Дра
  • Cyprus · Cilox, Medofloxine
  • Czechia · Floxal, Ofloxacin Unimed Pharma
  • Germany · Floxal, Floxal Edo
  • Estonia · Medofloxine, Ofloxin
  • Spain · Exocin, Oflovir
  • Finland · Exocin
  • France · Exocine, Monoflocet
  • United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
  • Greece · Exocin, Oxatrex
  • Croatia · Uniflox
  • Hungary · Floxal, Grenis-Oflo
  • Ireland · Exocin
  • Italy · Dunaflot, Exocin
  • Lithuania · Ofloxin, Uniflox
  • Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
  • Latvia · Ofloxin, Uniflox
  • Malta · Uniflox Unimed Pharma
  • Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
  • Poland · Floxal, Oflodinex
  • Portugal · Audret, Bioquil
  • Romania · Floxal, Ofloxacină Laropharm
  • Sweden · Ofloxacin Mibe
  • Slovakia · Medofloxine, Ofloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e42f6b6b-ad61-44b3-bbf0-1c1aeba40b9a
GET /v1/drugs/e42f6b6b-ad61-44b3-bbf0-1c1aeba40b9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": "3",
  "substance": "OFLOXACIN",
  "productndc": "24208-434",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA076622",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about ofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console